MLchartDataset catalogue

Clopidogrel bisulfate

Term · Oncology and biomedicine · MLC-T-ONC-012651

A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation.

Table 1. Record
IdentifierMLC-T-ONC-012651
FieldOncology and biomedicine
SynonymsPlavix
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012651",
  "term": "Clopidogrel bisulfate",
  "field": "Oncology and biomedicine",
  "definition": "A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation.",
  "synonyms": [
    "Plavix"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/clopidogrel-bisulfate/"
}

Record 4,988 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.